ose veins
(GSV; C2-C5)

EVLA (n ¼ 78);
HL&S (n ¼ 68)

UGFS with
physiciancompounded
foam (n ¼ 77)

At 1 year, EVLA was
superior to UGFS in
GSV closure (P < .001);
no differences in QoL

RCT

Lattimer et al,177
201